FDA Approved: OLANZAPINE — Supplemental Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic olanzapine product from Upsher-Smith Laboratories, LLC (ANDA204319).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Olanzapine (generic) (Olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)